Covered recipient · General Payments record
MICHELLE REBECCA BUDNICK
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2022–2024
$812.15
- Reported across 40 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $365.68 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $167.23 | 7 |
| E.R. Squibb & Sons, L.L.C. | $62.97 | 3 |
| Amgen Inc. | $21.74 | 1 |
| Celgene Corporation | $21.71 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $19.67 | 1 |
| UCB, Inc. | $19.16 | 1 |
| Verrica Pharmaceuticals Inc. | $18.84 | 1 |
| Biofrontera Inc. | $18.49 | 1 |
| Solventum Corporation | $15.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.30 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106843958 | CMS |
| ABBVIE INC. | $19.84 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106843960 | CMS |
| ABBVIE INC. | $29.99 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106843962 | CMS |
| ABBVIE INC. | $23.45 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106843964 | CMS |
| ABBVIE INC. | $23.81 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106843966 | CMS |
| ABBVIE INC. | $21.24 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106843968 | CMS |
| ABBVIE INC. | $24.60 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106843970 | CMS |
| Amgen Inc. | $21.74 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117516509 | CMS |
| Biofrontera Inc. | $18.49 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100676409 | CMS |
| Celgene Corporation | $21.71 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101185771 | CMS |
| E.R. Squibb & Sons, L.L.C. | $20.71 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101780078 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.26 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101780181 | CMS |
| E.R. Squibb & Sons, L.L.C. | $28.00 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101780206 | CMS |
| Novartis Pharmaceuticals Corporation | $19.67 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086740939 | CMS |
| Solventum Corporation | $15.87 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144087033 | CMS |
| UCB, Inc. | $19.16 | 07/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143170238 | CMS |
| Verrica Pharmaceuticals Inc. | $18.84 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118389836 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.